SFTPA1 and fatty liver disease: The reduced lipid accumulation in SPA-deficient mice observed in this study implies that SPA increases hepatic steatosis, compromising hepatocyte membrane integrity, allowing fluid influx and loss of cell shape with resultant swelling, and rounding up of hepatocytes (hepatocyte ballooning).